WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials Dividends Adv. Charts Earnings Options ... WebApr 13, 2024 · As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.1, which is expected to increase to -$0.08 for fiscal year -$0.43 and then to about -$0.29 by fiscal year 2024.
2024-04-10 NDAQ:CTIC Press Release CTI BioPharma Corp.
WebApr 11, 2024 · CTI BioPharma (CTIC) In a report released yesterday, Robert Hazlett from BTIG maintained a Buy rating on CTI BioPharma, with a price target of $9.00. The company’s shares closed last Monday at ... WebCTIC Stock 12 Months Forecast. Based on 7 Wall Street analysts offering 12 month price targets for CTI BioPharma in the last 3 months. The average price target is $11.30 with a … diagnosis code enlarged thyroid
CTI BioPharma Corp. (CTIC) Stock Price, News & Historical Data
WebCTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates. CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024 ... WebApr 10, 2024 · CTIC Stock Overview. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. ... Earnings-US$92.99m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-0.71: … WebStock CTIC . Posted: Apr 12 2024, 16:30. Author Name: PRNewsWire. Views: 041225. CTIC News . By PRNewsWire April 12, 2024. CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2024 ... CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended … diagnosis code f43.23 for behavioral health